Home   >  
Epigenetic Reader Domain

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

Epigenetic Reader Domain

Chemical Structure Cat. No. Product Name CAS No.
EML 425 Chemical Structure
BCP46797 EML 425 1675821-32-5
EML425 is a potent and selective CREB binding protein (CBP)/p300 inhibitor with IC50s of 2.9 and 1.1 μM, respectively.
CFT-8634 Chemical Structure
BCP46564 CFT-8634 2704617-96-7
CFT-8634 is a degrader targeting BRD9 extracted from patent WO2021178920A1 compound 173.
GSK1379725A Chemical Structure
BCP46513 GSK1379725A 1802251-00-8
GSK1379725A is the first selective inhibitor of BPTF over Brd4.
BAZ1A-IN-1 Chemical Structure
BCP46449 BAZ1A-IN-1 941521-45-5
BAZ1A-IN-1 is a potent inhibitor of BAZ1A (bromodomain-containing protein). BAZ1A-IN-1 shows a KD value of 0.52 μM against BAZ1A bromodomain.
M-525 Chemical Structure
BCP46311 M-525 2173582-08-4
M-525 is a first-in-class, highly potent, irreversible small-molecule inhibitor of the menin-MLL interaction.
dBRD9 Chemical Structure
BCP45901 dBRD9 2170679-45-3
dBRD9 is a potent and selective BRD9 bromodomain degrader composed of the BRD9 inhibitor BI 7273 conjugated to the cereblon E3 ligase ligand pomalidomide.
I-BET567 Chemical Structure
BCP45484 I-BET567 1887237-54-8
I-BET567 is a potent and orally active inhibitor of pan-BET candidate with pIC50s of 6.9 and 7.2 for BRD4 BD1 and BD2, respectively.
Bet-IN-4 Chemical Structure
BCP45446 Bet-IN-4 1801503-93-4
Bet-IN-4 is a highly potent, selective and orally active pan-BET inhibitor that has shown preclinical evidence of tumour growth inhibition in breast cancer and in leukaemia and prostate cancer xenograft models.
CTB Chemical Structure
BCP45206 CTB 451491-47-7
CTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.
PROTAC BRD4 ligand-1 Chemical Structure
BCP45084 PROTAC BRD4 ligand-1 2313230-51-0
PROTAC BRD4 ligand-1 is a potent inhibitor of BET .
123下一页末页共 134 条记录 1 / 14 页